Not applicableLooking for participantsNCT06324916What this trial is testingDonor Site Morbidity After Free Vascularized Fibular GraftWho this might be right forOsteosarcoma Assiut University 20
Not applicableStudy completedNCT03237884What this trial is testingRomanian-Swiss Research Programme IZERZOWho this might be right forAdvanced Incurable Cancer Cantonal Hospital of St. Gallen 308
Testing effectiveness (Phase 2)UnknownNCT05066607What this trial is testingIsatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous TherapyWho this might be right forAL Amyloidosis Intergroupe Francophone du Myelome 46
Testing effectiveness (Phase 2)UnknownNCT00333008What this trial is testingA Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Who this might be right forDiffuse Large B Cell LymphomaLymphoma, Non-Hodgkin The Alvin and Lois Lapidus Cancer Institute 27
Early research (Phase 1)UnknownNCT01341834What this trial is testingSafety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven TumorsWho this might be right forNasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour National Cancer Centre, Singapore 49
Large-scale testing (Phase 3)Study completedNCT03898180What this trial is testingStudy of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)Who this might be right forUrothelial Carcinoma Merck Sharp & Dohme LLC 505
Not applicableStudy completedNCT01241396What this trial is testingRecord in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any ProcedureWho this might be right forMultiple Myeloma Janssen Pharmaceutica N.V., Belgium 2,396
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128What this trial is testingSelpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)Who this might be right forNon-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more Eli Lilly and Company 857
Testing effectiveness (Phase 2)Study completedNCT04332653What this trial is testingNT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid TumorsWho this might be right forAny Advanced Solid TumorsTriple Negative Breast CancerNon Small Cell Lung Cancer+4 more NeoImmuneTech 215
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242
Testing effectiveness (Phase 2)Study completedNCT00456716What this trial is testingSorafenib in BAC or Never-Smokers With Lung AdenocarcinomaWho this might be right forLung Cancer Swedish Medical Center 5
Not applicableNo Longer AvailableNCT00655252What this trial is testingExpanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor TherapyWho this might be right forMetastatic Renal Cell Cancer Novartis Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT01246817What this trial is testingTemsirolimus-RCC-imagingWho this might be right forRenal Cell Cancer Radboud University Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT02601950What this trial is testingTazemetostat in Adult Participants With Soft Tissue SarcomaWho this might be right forMalignant Rhabdoid Tumors (MRT)Rhabdoid Tumors of the Kidney (RTK)Atypical Teratoid Rhabdoid Tumors (ATRT)+8 more Epizyme, Inc. 267
Early research (Phase 1)Active Not RecruitingNCT06218511What this trial is testingA Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)Who this might be right forHepatocellular Carcinoma National Cancer Institute, Naples 10
Not applicableStudy completedNCT04048564What this trial is testingObservational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)Who this might be right forChronic Myeloid Leukemia Incyte BioSciences France 120
Not applicableUnknownNCT03933852What this trial is testingObservational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any DoseWho this might be right forChronic Myeloid Leukemia, Chronic Phase University of Jena 100
Testing effectiveness (Phase 2)Ended earlyNCT01217411What this trial is testingRO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerWho this might be right forAdult Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaHER2/Neu Negative+10 more National Cancer Institute (NCI) 5
Not applicableStudy completedNCT05634395What this trial is testingDigital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of TreatmentWho this might be right forBreast Cancer Institut Curie 200
Not applicableStudy completedNCT01169545What this trial is testingCancer, Vulnerability, and Financial Quality of Life: A Mixed Methods StudyWho this might be right forCancer Georgetown University 90